A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination
Clinical trial NCT05911061 · UNKNOWN
Trial details
- NCT number
- NCT05911061
- Sponsor
- WestVac Biopharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2025-06-30
- Enrollment
- 4950
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.